Kyoung‐Ho Pyo

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

Chun‐Gon Kim, Kyoung‐Ho Kim, Kyoung‐Ho Pyo et al. · Annals of Oncology · 2019 · 301 citations · Full text

Medicine, Immunology, Oncology +15

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion–Driven NSCLC

Jiyeon Yun, Soo‐Hwan Lee, Seo-Yoon Jeong et al. · Cancer Discovery · 2020 · 288 citations · Full text

Medicine, Oncology, Pharmacology +17

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients

Hye Ryun Kim, Sang‐Jun Ha, Min Hee Hong et al. · Scientific Reports · 2016 · 260 citations · Full text

Medicine, Immunology, Pathology +14

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer

Jiyeon Yun, Min Hee Hong, Seok‐Young Kim et al. · Clinical Cancer Research · 2019 · 126 citations · Full text

Medicine, Oncology, Pharmacology +14

Toxoplasma gondii Infection in the Brain Inhibits Neuronal Degeneration and Learning and Memory Impairments in a Murine Model of Alzheimer's Disease

Bong-Kwang Jung, Kyoung‐Ho Pyo, Ki Young Shin et al. · PLoS ONE · 2012 · 107 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17